215 related articles for article (PubMed ID: 23568010)
1. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer.
Faltejskova P; Bocanek O; Sachlova M; Svoboda M; Kiss I; Vyzula R; Slaby O
Cancer Biomark; 2012; 12(4):199-204. PubMed ID: 23568010
[TBL] [Abstract][Full Text] [Related]
2. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
3. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
4. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
Ramzy I; Hasaballah M; Marzaban R; Shaker O; Soliman ZA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):508-15. PubMed ID: 25736690
[TBL] [Abstract][Full Text] [Related]
9. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
Luo X; Stock C; Burwinkel B; Brenner H
PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
[TBL] [Abstract][Full Text] [Related]
10. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
[TBL] [Abstract][Full Text] [Related]
11. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-20a and miR-486 are potential biomarkers for discriminating colorectal neoplasia: A pilot study.
Yang Q; Wang S; Huang J; Xia C; Jin H; Fan Y
J Cancer Res Ther; 2018; 14(7):1572-1577. PubMed ID: 30589041
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
17. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
Wanram S; Klaewkla N; Pinyosri P
Microrna; 2024; 13(1):56-62. PubMed ID: 38231064
[TBL] [Abstract][Full Text] [Related]
19. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM
Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863
[TBL] [Abstract][Full Text] [Related]
20. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]